Business
NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
LANGHORNE, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the financing of $1.797 million relating to a potential acquisition targeted for the first quarter of 2026. The potential acquisition is subject to the completion of due diligence by both NEXGEL
About this update from Nexgel, Inc
[{"type":"image","alt":"NEXGEL, INC.","displaySize":"","headline":null,"caption":"NEXGEL, INC.","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":66,"url":"https://media.zenfs.com/en/globenewswire.com/7f0d3c847df57a7d87b54e7056dbb4aa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ONAbP5tUr9hDfjARTjK8NA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7f0d3c847df57a7d87b54e7056dbb4aa","width":250,"height":66}},"lazy":false},{"type":"text","content":"LANGHORNE, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced the financing of $1.797 million relating to a potential acquisition targeted for the first quarter of 2026. The potential acquisition is subject to the completion of due diligence by both NEXGEL and the investor. The funds will be returned to the investor should the transaction not be consummated.","length":604,"tagName":"p"},{"type":"text","content":"“After successfully closing and integrating several acquisitions over the last several years, we have continued to evaluate other potential accretive transactions,” said Adam Levy, CEO of NEXGEL. “We have identified assets to acquire with an up-front commitment from an investor in the amount of $1.797 million and a potential additional investment of $14.869 million relating to the acquisition, pending the completion of full due diligence by both parties and subject to other conditions. We expect to provide shareholders with further information on the acquisition during the first quarter of 2026.”","length":603,"tagName":"p"},{"type":"text","content":"Palladium Capital Group, LLC acted as the placement agent on the transaction.","length":77,"tagName":"p"},{"type":"text","content":"The financing transaction is more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 10, 2026.","length":155,"tagName":"p"},{"type":"text","content":"About NEXGEL, Inc.NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer...